(Q27853110)

English

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

PubMed publication ID

13 November 2016

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study. (English)

1 reference

PubMed publication ID

13 November 2016

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Igor N. Bondarenko

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Richard S Finn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

John P Crown

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Istvan Lang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Katalin Boer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sergey O Kulyk

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Johannes Ettl

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ravindranath Patel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Tamas Pinter

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Marcus Schmidt

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Yaroslav Shparyk

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Anu R Thummala

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Nataliya L Voytko

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Camilla Fowst

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Xin Huang

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sindy T Kim

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sophia Randolph

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Dennis J Slamon

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

January 2015

0 references

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

25-35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell cycle, CDKs and cancer: a changing paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitors of cell cycle kinases: recent advances and future prospects as cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Signaling through cyclin D-dependent kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing concepts of hormone receptor-positive advanced breast cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganitumab with either exemestane or fulvestrant for postmenopausal women with advanced, hormone-receptor-positive breast cancer: a randomised, controlled, double-blind, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2971159-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)71159-3

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25524798%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853110&oldid=2111276966"